Skip to main content
Press Release RSS Feed (opens in new window)

Press Releases

Press release year list 2019 2018 2017 2016 2015 2014 2013
Trillium Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update
November 14, 2019
Trillium Therapeutics to Report Preclinical Data on Its STING Program at the SITC 34th Annual Meeting
November 6, 2019
Trillium Therapeutics Announces Corporate Restructuring and Provides CD47 Program Update
October 22, 2019
Trillium Granted 180-Day Extension by NASDAQ to Regain Compliance With Minimum Bid Price Rule
October 8, 2019
Download PDF format download (opens in new window)
Trillium Therapeutics Appoints Jan Skvarka as President and Chief Executive Officer
September 25, 2019
Download PDF format download (opens in new window)
Trillium Therapeutics To Present At Investor Conference
September 5, 2019
Download PDF format download (opens in new window)
Trillium Therapeutics Reports Second Quarter 2019 Financial Results
August 13, 2019
Trillium Therapeutics Provides Corporate Update
July 24, 2019
Download PDF format download (opens in new window)
Trillium Announces Voting Results From the Annual and Special Meeting of Shareholders
July 2, 2019
Download PDF format download (opens in new window)
Trillium Therapeutics Reports First Quarter 2019 Financial Results
May 13, 2019
Download PDF format download (opens in new window)
Trillium Announces Management and Board Changes and Provides Corporate Update
April 30, 2019
Download PDF format download (opens in new window)
Trillium Therapeutics Announces Publication Highlighting Activity of TTI-621 in Sézary Syndrome Patients
April 15, 2019
Download PDF format download (opens in new window)
Trillium Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
April 11, 2019
Download PDF format download (opens in new window)
Trillium Therapeutics to Present at Investor Conferences in April
April 8, 2019
Download PDF format download (opens in new window)
Trillium Therapeutics Expands Immuno-Oncology Pipeline With STING Agonist Program
April 2, 2019
Download PDF format download (opens in new window)
Trillium Therapeutics to Unveil its STING Agonist Program at the AACR Annual Meeting 2019
March 27, 2019
Download PDF format download (opens in new window)
Trillium Therapeutics Reports Annual Financial and Operating Results
March 11, 2019
Download PDF format download (opens in new window)
Trillium Announces Closing of US$15 Million Public Offering of Common Share Units and Series II Non-Voting Convertible First Preferred Share Units
March 8, 2019
Download PDF format download (opens in new window)
Trillium Announces Pricing of US$15 Million Public Offering of Common Share Units and Series II Non-Voting Convertible First Preferred Share Units
February 22, 2019
Download PDF format download (opens in new window)
Trillium Announces Proposed Public Offering of Common Share Units and Series II Non-Voting Convertible First Preferred Share Units
February 21, 2019
Download PDF format download (opens in new window)